Evaluation of psychopathological symptoms, death anxiety, coronavirus anxiety, suicide risk, and associated risk factors among hemodialysis patients in the COVID-19 pandemic
- PMID: 35770373
- PMCID: PMC9349445
- DOI: 10.1111/1744-9987.13905
Evaluation of psychopathological symptoms, death anxiety, coronavirus anxiety, suicide risk, and associated risk factors among hemodialysis patients in the COVID-19 pandemic
Abstract
Background: Hemodialysis (HD) patients have significant mental health problems related to the COVID-19 pandemic. Thus, this study aimed to evaluate the psychopathological symptoms, death anxiety, coronavirus anxiety, suicide risk, and associated risk factors in HD patients during COVID-19.
Methods: This cross-sectional study was conducted from July 15 to October 15, 2021, with 114 HD patients who were undergoing treatment in two central dialysis units.
Results: It was determined that HD patients had high levels of psychopathological symptoms. Approximately, one-third of HD patients (31.6%) had high to very high-level death anxiety. Additionally, of the participants 30.7% had coronavirus anxiety, and also the rate of severe suicide risk was 10.5%.
Conclusions: HD patients have experienced various mental health problems during the COVID-19 pandemic. Psychosocial support and interventions need to be planned by the healthcare system and healthcare providers to help HD patients in managing their disease and related mental health problems.
Keywords: COVID-19; coronavirus anxiety; death anxiety; hemodialysis patients; psychopathology; suicide risk.
© 2022 International Society for Apheresis and Japanese Society for Apheresis.
Conflict of interest statement
The author declares that there is no conflict of interest.
References
-
- World Health Organization , Coronavirus. 2020. Available from: https://www.who.int/health-topics/coronavirus. Accessed 18 Feb 2022.
-
- Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382(9887):158–69. - PubMed
-
- Seyahi N, Ateş K, Süleymanlar G. Türkiye'de Renal Replasman Tedavilerinin Güncel Durumu: Türk Nefroloji Derneği Kayıt Sistemi 2015 Yılı Özet Raporu. Türk Nefroloji Diyal ve Transplant Derg. 2017;26:154–60.
-
- Alavi NM, Aliakbarzadeh Z, Sharifi K. Depression, anxiety, activities of daily living, and quality of life scores in patients undergoing renal replacement therapies. Transplant Proc. 2009;41(9):3693–6. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
